Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL have?
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL has 364 citations in the OpenAlex counts ScholarIQ stores.
When was Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL published?
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL has 2021 year in the ScholarIQ index.
What is the open-access status of Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL?
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL has green oa status in the ScholarIQ index.
What is the DOI of Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL?
The DOI for Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL is on the source record.
What is the PMID of Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL?
The PMID for Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL is on the source record.
What is the OpenAlex record for Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL?
The OpenAlex for Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL is on the source record.